NEW YORK, NY--(Marketwire - Dec 3, 2012) - The [ International Society for Cancer Risk Assessment and Management (ISC-RAM) ] is the first international, collaborative, multidisciplinary group whose mission is to advance the field of cancer risk assessment and promote effective strategies for education, surveillance, and cancer risk reduction. The first founders meeting took place on September 23-24^th and was sponsored by [ Atossa Genetics, Inc. ] (NASDAQ: [ ATOS ]). The Co-Presidents and Medical Directors are Banu Arun, M.D. from University of Texas, MD Anderson Cancer Center and Freya Schnabel, M.D. from New York University (NYU) Langone Medical Center. The Secretary/Treasurer and Executive Director is Jennifer Chun Kim, MPH from NYU Langone Medical Center. 

The inaugural steering committee meeting of ISC-RAM will convene on December 6, 2012, during the 2012 [ CTRC-AACR San Antonio Breast Cancer Symposium ], which takes place December 4-8, 2012. This meeting is sponsored by [ Atossa Genetics, Inc. ], [ Myriad Genetics ], and [ Cianna Medical. Inc ]. Healthcare professionals interested in joining and taking part of this important new initiative should contact Jennifer Chun Kim at ISC-RAM headquarters in New York at (212) 731-5333 or via email at [ jennifer.chun@nyumc.org ].

"ISC-RAM is the first society focused on advancing the knowledge of cancer risk assessment and education globally, which currently does not exist," said Banu Arun, M.D., Director of Clinical Cancer Genetics and Clinical Cancer Prevention Program at the MD Anderson Cancer Center. 

"By focusing on cancer risk assessment and management, this multidisciplinary group will facilitate efforts to reduce the burden of cancer in our society," said Freya Schnabel, M.D., Director of Breast Surgery at NYU Langone Medical Center.

About the International Society for Cancer Risk Assessment and Management (ISC-RAM)

The [ International Society for Cancer Risk Assessment and Management (ISC-RAM) ] is a collaborative, multidisciplinary group whose mission is to advance the field of cancer risk assessment and promote effective strategies for education, surveillance, and cancer risk reduction.